Travoprost

Study of Exchange of Travoprost Intraocular Implant

A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Stop Retinal Ganglion Cell Dysfunction Study

Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT

Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension

The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye

Effects of Anti-Glaucoma Medications on the Ocular Surface

Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost

Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost

24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension

Effect of Selective Laser Trabeculoplasty Versus Travoprost on Circardian Intraocular Pressure

Glaucoma Intensity Treatment Study – Intensive non-invasive glaucoma treatment vs conventional stepwise treatment – a prospective, randomized phase IV study of disease progression in glaucoma

Effects of Travoprost on Neovascular Glaucoma

Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma

Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg